Attention Deficit Hyperactivity Disorder (ADHD) News and Research

RSS

Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral).

Children with DCD tend to feel more emotionally isolated, less coherent and less optimistic

Attention Deficit Hyperactivity Disorder, or ADHD, is widely recognized by the medical community, and there are a number of therapies in place. But as many as six percent of all children suffer from the less familiar Developmental Coordination Disorder (DCD). Demonstrating a lack of refined motor skills, children with DCD tend to have a more difficult time playing sports and staying organized at school. They appear to be uncoordinated - and many parents think they'll grow out of it. But research shows that may not be true.

5 Apr 2011

LifeSpan medicine launches new health and wellness program for kids

LifeSpan medicine is excited to announce the launch of the LifeSpan Healthy Kids Program. There is nothing more important to a lifespan of health than a good start. Who would not want to have a better, healthier childhood for their kids than they themselves had?

1 Apr 2011

Early recognition and treatment can control obsessive-compulsive manifestation

Obsessive-compulsive disorder is often diagnosed too late in children and adolescents. In the current issue of Deutsches Ärzteblatt International, Susanne Walitza and her colleagues point out that appropriate early recognition and treatment can positively affect the course of the disease.

1 Apr 2011

FDA panel to decide regarding food dyes and hyperactivity

A Food and Drug Administration panel is opening a two-day meeting on the link between artificial food dyes and hyperactivity in children. These dyes are used to color the cereals and snacks for children.

30 Mar 2011

Positive top-line results from Targacept's TC-5619 Phase 2 trial in adults with ADHD

Targacept, Inc today announced top-line results from a Phase 2 proof of concept trial of TC-5619 as a treatment for adults with attention deficit/hyperactivity disorder.

25 Mar 2011

Children with epilepsy more likely to have psychiatric symptoms

A newly published report reveals that children with epilepsy are more likely to have psychiatric symptoms, with gender a determining factor in their development.

25 Mar 2011

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

BioMarin Pharmaceutical Inc. announced today preliminary results from ADAPT (A Diversified Approach for PKU Treatment) in an abstract (Abstract #91, Mental Health Screening in Phenylketoniuria Clinic) presented by Barbara Burton, MD at the 2011 annual American College of Medical Genetics conference in Vancouver, Canada.

19 Mar 2011

Special report takes critical look at debates about pediatric problematic moods, behaviors

Decisions about whether and how to diagnose children with emotional and behavioral disturbances, and whether and how to treat them, are sometimes not clear-cut. When decisions lie within a "zone of ambiguity," people who emphasize different value commitments can reach different but equally respectable conclusions.

17 Mar 2011

Supernus SPN-812 Phase IIa U.S. clinical trial in ADHD meets primary endpoints

Supernus Pharmaceuticals, Inc. today announced that its Phase IIa U.S. clinical trial of SPN-812 in adults for the treatment of attention deficit hyperactivity disorder (ADHD) met the primary endpoints of safety and tolerability, and showed statistically significant median reduction versus placebo in both investigator-rated and patient-rated ADHD symptom scores.

11 Mar 2011

American Botanical Council honors excellence in herbal medicine

The 6th Annual American Botanical Council Celebration and Awards Ceremony took place last night, honoring individuals and companies who influence the present and future of the herbal medicine movement. The ABC event is part of the annual Natural Products Expo West trade show and Nutracon scientific conference, held in Anaheim, California.

11 Mar 2011

Camp STAR to offer evidence-based therapy for children with ADHD

Camp STAR, the Chicago area's only summer camp offering evidence-based therapy for children with Attention Deficit/Hyperactivity Disorder and other behavioral, emotional and social difficulties, begins its fourth season in June.

9 Mar 2011

CPCHE launches multi-year project to promote healthier home energy retrofits

Home energy retrofits tackle climate change and when done right they should make homes healthier, while aiding families struggling with utility bills.

6 Mar 2011

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Thanks in part to a Norwegian research biobank, researchers have generated important new insight into ADHD and how the condition manifests itself. Among other things, they have found that there is some overlap between ADHD and bipolar disorders with regard to rapid mood swings.

2 Mar 2011

Sleep loss have negative impact on neurobehavioral functioning in children with ADHD

A new study in the March 1 issue of the journal Sleep indicates that the ability of children with attention deficit hyperactivity disorder to remain vigilant and attentive deteriorated significantly after losing less than one hour of nightly sleep for a week.

2 Mar 2011

New research finds link between genomic variants in neurological processes and autism

New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered.

2 Mar 2011

KemPharm commences KP201 Phase 1 trial for pain

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers with KP201, its novel abuse deterrent prodrug of hydrocodone for pain. KP201 is a new chemical entity and is the most advanced opioid-based lead candidate in KemPharm's emerging pipeline.

22 Feb 2011

Amphetamine linked to development of Parkinson’s disease

New research suggests that taking prescription amphetamines may raise the risk of developing Parkinson’s disease later. But, the researchers noted that the study did not prove a cause-and-effect relationship and further investigation is warranted. The research was released Feb. 19, and is scheduled to be presented in April at the American Academy of Neurology’s annual meeting in Honolulu.

21 Feb 2011

Amphetamines appear to increase risk of developing Parkinson's disease: New research

New research shows people who have used amphetamines such as benzedrine and dexedrine appear to be at an increased risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

20 Feb 2011

Children with chronic health conditions may face increased risk of physical abuse

Children with chronic health conditions are 88% more likely to suffer physical abuse than healthy children, according to research in the March issue of Acta Paediatrica. They are also 154% more likely to suffer a combination of physical abuse and exposure to intimate partner violence than their healthy school friends.

17 Feb 2011

Measurements of hand movement control may help determine severity of ADHD in children

Measurements of hand movement control may help determine the severity of attention deficit hyperactivity disorder in children, according to joint studies published in the February 15, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

15 Feb 2011

Attention Deficit Hyperactivity Disorder (ADHD) News and Research

Further Reading

Children with DCD tend to feel more emotionally isolated, less coherent and less optimistic

LifeSpan medicine launches new health and wellness program for kids

Early recognition and treatment can control obsessive-compulsive manifestation

FDA panel to decide regarding food dyes and hyperactivity

Positive top-line results from Targacept's TC-5619 Phase 2 trial in adults with ADHD

Children with epilepsy more likely to have psychiatric symptoms

BioMarin announces preliminary results from ADAPT in patients suffering from PKU

Special report takes critical look at debates about pediatric problematic moods, behaviors

Supernus SPN-812 Phase IIa U.S. clinical trial in ADHD meets primary endpoints

American Botanical Council honors excellence in herbal medicine

Camp STAR to offer evidence-based therapy for children with ADHD

CPCHE launches multi-year project to promote healthier home energy retrofits

Scientists find link between ADHD and bipolar disorders with regard to rapid mood swings

Sleep loss have negative impact on neurobehavioral functioning in children with ADHD

New research finds link between genomic variants in neurological processes and autism

KemPharm commences KP201 Phase 1 trial for pain

Amphetamine linked to development of Parkinson’s disease

Amphetamines appear to increase risk of developing Parkinson's disease: New research

Children with chronic health conditions may face increased risk of physical abuse

Measurements of hand movement control may help determine severity of ADHD in children

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News